Accepted at 3:58 a.m. Nov, 01, 2023 by Cameron
Author: Huzaifa
Related Note: 1463675409153
Rationale for change

It is incorrect to say that bisphosphonates are useful acutely. They should be started with calcitonin but their effect has a slow onset.
Source: AMBOSS - https://next.amboss.com/us/article/UI0bXh?q=hypercalcemia#Ze68781981f01766eb6f2131c36ab51f2

Text Text
Extra
Referring to the hypercalcemia induced by PTHrP as a paraneoplastic syndrome
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo





OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::04_Parathyroid::02_The_Unhealthy_Parathyroid_Calcium_Disorders #AK_Original_Decks::Step_1::Zanki_Pharmacology #PANCE::EOR::PEDS #AK_Step2_v12::#OME::01_Medicine::04_Nephrology::04_Calcium !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step2_v12::#Subjects::Endocrinology::04_Parathyroid_Gland::Hypercalcemia::Humoral_Hypercalcemia_of_Malignancy #AK_Step2_v12::Original_decks::Dorian::fam::amboss #PANCE::ENDO::parathyroid_disorders #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step2_v12::#UWorld::Step::2599 #AK_Step2_v12::#SketchyIM::06_Electrolytes_&_Acid_Base::04_Retired_Lessons::05_Hypercalcemia_Ddx_&_Managment_[OLD_VERSION] #AK_Step2_v12::#B&B::15_Renal_and_Genitourinary::02_Fluids_and_Electrolytes::05_Calcium_Magnesium_and_Phosphate_Disorders::Extra #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::06_Bisphosphonates #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::04_Parathyroid::02_The_Unhealthy_Parathyroid_Calcium_Disorders #AK_Step2_v12::#AMBOSS::yx0d_R #AK_Step2_v12::#UWorld::COMLEX::28411 #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::03_Thyroid,_Parathyroid,_Adrenal::02_Bisphosphonates,_Raloxifene,_Denosumab,_Calcitonin #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::07_Bisphosphonates #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::07_Bisphosphonates #AK_Step2_v12::#Resources_by_rotation::IM::ome::renal::calcium #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::06_Bisphosphonates_Denosumab_Teriparatide